Invistics

Monthly Archives: October 2016

DEA Reduces Amount of Opioid Controlled Substances that may be Manufactured in 2017

10/05/2016

Yesterday, the United States Drug Enforcement Administration (DEA) dramatically decreased the amount of Schedule II opiate and opioid drugs that may be manufactured in 2017. Almost all of the reductions were 25% or more, with 33% reduction to hydrocodone. The… more →

Rhythm Wheel Optimization with Cadence Advisor

10/04/2016

Cadence Advisor is a ‘workbench’ module in the Flowlytics suite that allows planners to rapidly evaluate many possible production cadences (aka ‘rhythm cycles’ or ‘rhythm wheels’) to minimize overall costs while creating a smooth and repeatable manufacturing sequence. Planners are… more →